Last updated on September 2018

Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine


Brief description of study

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

Clinical Study Identifier: NCT02974153

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.